TGA Approval

COSENTYX secukinumab (rch) 150 mg powder for injection vial (218798)

ARTG ID

218798

ARTG Name

COSENTYX secukinumab (rch) 150 mg powder for injection vial

Sponsor

Novartis Pharmaceuticals Australia Pty Ltd

ARTG Date

January 12, 2015

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

Novartis Pharmaceuticals Australia Pty Ltd.

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2015-PI-01060-1

Ingredient Name

Secukinumab

Empowering clinical research with data-driven insights and AI-powered tools.

COSENTYX secukinumab (rch) 150 mg powder for injection vial (218798) - TGA 批准文号 | MedPath